The online platform C19economics was created to support researchers and decision makers by collating the health economic literature published on the COVID-19 pandemic into an easily searchable repository. After reviewing the literature, we found three notable gaps in coverage in terms of geographical focus and topic areas.
CGD Policy Blogs
The New C19economics.org: A Platform to Support the Generation and Use of Health Economics Research to Tackle COVID-19
Since the beginning of the COVID-19 outbreak, the scientific community has worked around the clock to produce evidence to support decision-makers in all aspects of pandemic management. As of April 2021, there are more than 78,000 articles published in peer reviewed journals and pre-prints (as indexed by collabovid.org). Those unprecedented collective research efforts have supported decisionmakers across the world on some of the toughest choices in decades, from closing economies, to procuring vaccines and medical supplies and equipment, and preparing for the uncertain year ahead.
In this blog, we describe some major global efforts that examine whether essential health services have been disrupted during the pandemic, summarize what they tell us, and highlight some of the remaining gaps in our understanding and knowledge.
Since the beginning of the COVID-19 pandemic, reports about the indirect health impacts of COVID have been published in nearly all countries. In May we published a tool to estimate the net health impact of COVID-19 policies, and have updated the tool here.
Since April 2020, a group of national governments, funders, and development partners supporting COVID-19 responses in low- and middle-income countries have been working together as the COVID-19 Multi-model Comparison Collaboration (CMCC) to support the use of epidemiological models during the COVID-19 pandemic. Today, the CMCC releases its first two outputs—an important step towards enhancing the informed use of models in COVID-related policymaking.
This blog highlights the impact of living through a pandemic on mental health, including worsening substance abuse disorders, and on nutrition and access to primary health care.
As the world battles COVID-19, practical investments are urgently needed to ensure that decision-makers consult the best and most relevant evidence on COVID-19 before making a decision.
In this blog, we highlight reports of substantial long-term impacts of the COVID-19 response on health systems, ranging from government reductions in health spending to sharp decreases in utilisation of health services across health areas.
This blog unveils a framework that can help policymakers move to a holistic COVID-19 response that accounts for the impacts of the pandemic and the measures implemented to fight it.
With a focus on tests, treatments, and a vaccine, we take a look at the emerging global clinical and economic evidence-base underpinning some of these technologies, the mechanisms (mostly global) for financing these commodities, and, finally, the decision-making processes for selecting technologies. This includes identifying the right subpopulations and negotiating a cost-effective tiered price across countries and regions.